17 results
10-Q
2024 Q1
NAMS
NewAmsterdam Pharma Company N.V.
8 May 24
Quarterly report
4:30pm
member states. Failure to comply with these requirements could result in reputational risk, public reprimands, administrative penalties, fines
10-K
2023 FY
NAMS
NewAmsterdam Pharma Company N.V.
28 Feb 24
Annual report
8:00am
, applicable in the EU member states. Failure to comply with these requirements could result in reputational risk, public reprimands, administrative
424B3
NAMS
NewAmsterdam Pharma Company N.V.
15 Aug 23
Prospectus supplement
4:52pm
to comply with these requirements could result in reputational risk, public reprimands, administrative penalties, fines or imprisonment.
Federal false
POS AM
NAMS
NewAmsterdam Pharma Company N.V.
7 Aug 23
Prospectus update (post-effective amendment)
7:56am
result in reputational risk, public reprimands, administrative penalties, fines or imprisonment.
Federal false claims laws, including the federal
6-K
EX-99.2
ob827shcj5ik6e
7 Aug 23
Research and development expenses
7:24am
424B3
6ayo5 r7dae5q
8 Jun 23
Prospectus supplement
5:01pm
424B3
dv2exvb4zrbcezowm4bh
6 Jun 23
Prospectus supplement
4:20pm
424B3
nwryy4mvu9 88k4
25 Apr 23
Prospectus supplement
8:14am
POS AM
v06hy0or
17 Apr 23
Prospectus update (post-effective amendment)
9:09am
F-1
a15qrhq
19 Dec 22
Registration statement (foreign)
6:22pm
424B3
1w00wvnz irm1
18 Oct 22
Prospectus supplement
4:41pm
F-4/A
iqultqr8pvouaxjf
13 Oct 22
Registration of securities (foreign) (amended)
5:18pm
F-4/A
mfjp evs3sly
3 Oct 22
Registration of securities (foreign) (amended)
5:12pm
F-4/A
gi1i9riwoedgvcp
13 Sep 22
Registration of securities (foreign) (amended)
5:03pm
F-4
ry2ikxpk
4 Aug 22
Registration of securities (foreign)
8:02am
- Prev
- 1
- Next